Key facts
- Oculomex Health’s last known valuation is $2.4M (Nov 2025).
- It has raised $420K; the latest was Seed Round ($420K) in Nov 2025.
- Notable investors include SFC Capital.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Oculomex Health
- ·The full record, as it builds
Funding rounds
No funding rounds for Oculomex Health are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oculomex Health
Developer of an artificial intelligence-driven cardiovascular screening platform designed for systemic health monitoring through ocular analysis. The company's platform utilizes machine learning algorithms to evaluate non-invasive retinal images by identifying vascular biomarkers such as vessel narrowing and tortuosity, enabling healthcare providers and research institutions to assess risks for conditions like hypertension and atherosclerosis through the integration of physiological and radiomic data for diagnostic observation.
- Sector
- Healthcare
- HQ
- London, United Kingdom
- Founded
- 2024
- Website
- oculomex.com/
- Ownership
- Privately Held (backing)
Oculomex Health doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oculomex Health shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oculomex Health in its N-PORT filings yet. We sweep new filings monthly.